Keeping an eye on $ZBRA after a steep earnings-driven reset despite 22% sales growth, 11% organic growth, stronger earnings and a higher full-year outlook. The gap deserves another look, but lower gross margin, memory costs and a large 2027 refinancing need remain meaningful risks. There may still be details the market is pricing in that I haven't caught yet; this is a watch, not a verdict.
40 views
0 Comments
No comments available.
Join the conversation with 500,000+ other investors 💸
Create an account to get access to everything Blossom has to offer!
📊 Personalized algorithm based on your investing style, experience level and interests
📈 Powerful portfolio and dividend tracking tools
👀 See what top creators and others in the community are investing in
